Last updated on April 2019

Study to Assess the Safety and Effectiveness of Beltavac Polymerised With Alternaria Alternata

Brief description of study

Non-interventional Study to Assess the Safety and Effectiveness Profile of a SCIT Therapy With Beltavac Polymerised With Alternaria alternata in allergic patients

Detailed Study Description

This prospective open multi-centre non-interventional study assess the safety and effectiveness profile of the subcutaneous allergen-specific immunotherapy with Beltavac polimerizado in Alternaria alternata allergic patients (children and adults) in routine medical care.

Patients receive a rush schedule administration every month for a year. They attend at least 4 study visits to inform about the adverse reactions, the self reported symptoms and the medication intake.

Clinical Study Identifier: NCT03604718

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.